Daijiworld Media Network - Washington

Washington, Mar 20: The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of nearly 90,000 bottles of children’s ibuprofen due to possible contamination.

According to the agency’s enforcement report, 89,592 bottles of Children’s Ibuprofen Oral Suspension manufactured by Strides Pharma are being recalled over the “presence of foreign substance.”

The product—100 mg per 5 mL oral suspension sold in 4 fl oz (120 mL) bottles—was manufactured for Taro Pharmaceuticals USA and distributed across the United States.

The recalled bottles carry lot numbers 7261973A and 7261974A, with an expiration date of January 31, 2027. The recall was voluntarily initiated by Strides Pharma Inc., based in New Jersey.

The FDA said the action followed consumer complaints reporting “a gel-like mass and black particles” in the medicine. The recall was initiated on March 2 and has been classified as a Class II recall.

A Class II recall indicates that use of the product may cause temporary or medically reversible health effects, while the likelihood of serious adverse consequences is considered low.

Authorities have advised consumers to immediately stop using the affected product. Further guidance on returns or replacements has not yet been detailed.

The recall highlights ongoing concerns around quality control in pharmaceutical products, especially those intended for children.